[Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer]
- PMID: 4040730
[Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer]
Abstract
Twenty one patients with advanced bladder cancer (metastases and/or loco-regional recurrences) were treated by cisplatin-based chemotherapy (cisplatin, adriamycin, cyclo-phosphamide (8 patients), cisplatin, methotrexate (8 patients) and cisplatin and radiotherapy (5 patients). The results with pure chemotherapy were, on the whole, disappointing, with a remission rate of 25% and a response rate of 50%. Only the combination of cisplatin-based chemotherapy and radiotherapy gave spectacular results with 50% complete response, but even then at the price of a high morbidity rate.
Similar articles
-
Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.Jpn J Clin Oncol. 1993 Oct;23(5):291-8. Jpn J Clin Oncol. 1993. PMID: 7693990 Clinical Trial.
-
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088. Urology. 2004. PMID: 15351577 Review.
-
[Systemic chemotherapy in advanced bladder cancer. New aspects].Wien Klin Wochenschr. 1987 Jan 23;99(2):54-7. Wien Klin Wochenschr. 1987. PMID: 3564487 German.
-
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].Hinyokika Kiyo. 2006 May;52(5):331-5. Hinyokika Kiyo. 2006. PMID: 16758720 Clinical Trial. Japanese.
-
[Recent controversy in treatment for advanced bladder cancer].Gan To Kagaku Ryoho. 1998 Sep;25(11):1696-700. Gan To Kagaku Ryoho. 1998. PMID: 9757194 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical